Surgical Sutures Market is
expected to reach $5,255 million by 2022, growing at a CAGR of 6.4% from 2016
to 2022. The sutures segment dominated the market in 2015 with more than four-fifths
share.
Global escalation in the number of hospitals, surge in the adoption of technologically advanced products, and increase in number of surgeries due to geriatric population & patients with various chronic diseases are the major factors that drive the growth of surgical sutures market. However, the adoption of substitute products such as advanced wound closure materials and lack of proper sterilization process in healthcare settings are projected to hinder the market growth.
Global escalation in the number of hospitals, surge in the adoption of technologically advanced products, and increase in number of surgeries due to geriatric population & patients with various chronic diseases are the major factors that drive the growth of surgical sutures market. However, the adoption of substitute products such as advanced wound closure materials and lack of proper sterilization process in healthcare settings are projected to hinder the market growth.
Download PDF Report
Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/1642
The key players in the surgical suture market
are expanding their business operations in the developing countries with new
product launches. Comprehensive profiles of major market players such as
Johnson & Johnson Private Limited, B. Braun Melsungen AG, Smith &
Nephew, Demetech Corporation, Conmed Corporation, W.L. Gore & Associates,
Boston Scientific, 3M Healthcare, Medtronic Inc., and Sutures India Pvt Ltd.
are provided in this report.
The sutures segment accounted for more than
four-fifths share of the market in 2015, and is expected to dominate the
market, growing at a CAGR of 6.3%. The absorbable suture dissolves in tissues
after a period of time and heals the wound, whereas non-absorbable suture is to
be removed after the incision is healed. The absorbable suture segment held the
largest share in 2015, and is anticipated to continue its dominance.
By material, the multifilament segment accounted for the largest share in the sutures market in 2015, and is estimated to grow with a CAGR of 6.6%. In the same year, the general surgeries application segment dominated the market with more than one-third share due to the increase in demand for surgical sutures in various types of abdominal and other general surgeries.
By material, the multifilament segment accounted for the largest share in the sutures market in 2015, and is estimated to grow with a CAGR of 6.6%. In the same year, the general surgeries application segment dominated the market with more than one-third share due to the increase in demand for surgical sutures in various types of abdominal and other general surgeries.
Key findings of the Surgical
Sutures Market:
·
In the year 2015, suture was the leading segment that accounted
for 85.4% of the suture market, and is projected to grow at a CAGR of 6.3%
during the forecast period.
·
North America accounted for the share of 44.5% of the in 2015,
and is projected to grow at a CAGR of 6.1%.
·
The prolene suture segment showed the highest growth in the non-absorbable
sutures market, and is projected to continue its lead.
·
U.S. is the major shareholder in the North American region,
accounting for 91.5% share in 2015.
·
Germany is the major shareholder in the Europe, accounting for
19.7% share in 2015.
North America was the highest revenue
contributor and Asia-Pacific showed fastest growth, accounting for 19.2% share
in 2015. The large share of North America is attributed to the higher adoption
of technologically advanced products such as absorbable & antibacterial
coated sutures, growth in surgical procedures with increase in prevalence of various
chronic diseases, and the development of the wound management sector. However,
Asia-Pacific is projected to grow at a the fastest CAGR due to rise in demand
for surgical procedures from large pool of patient population suffering from
diabetes, cardiovascular diseases, coronary thrombosis, cancer, and others.

No comments:
Post a Comment